rs781371665
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000368.5(TSC1):c.2380C>T(p.Gln794*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000368.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSC1 | ENST00000298552.9 | c.2380C>T | p.Gln794* | stop_gained | Exon 18 of 23 | 1 | NM_000368.5 | ENSP00000298552.3 | ||
TSC1 | ENST00000490179.4 | c.2380C>T | p.Gln794* | stop_gained | Exon 19 of 24 | 3 | ENSP00000495533.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The Q794X nonsense variant in the TSC1 gene has been reported previously in multiple unrelatedindividuals with a clinical diagnosis of tuberous sclerosis complex, including two individuals with denovo variants (Pompili et al., 2009; TSC1 LOVD). This pathogenic variant is predicted to cause lossof normal protein function either through protein truncation or nonsense-mediated mRNA decay.Furthermore, the Q794X variant is not observed in large population cohorts (Lek et al., 2016). Therefore, the presence of Q794X is consistent with the diagnosis of TSC in this individual. -
The TSC1 c.2380C>T, p.Gln794Ter variant (rs781371665) is reported in the literature in several individuals with a diagnosis of tuberous sclerosis (Jiang 2021, Peron 2018, Pompili 2009). This variant is also reported in ClinVar (Variation ID: 489349), but is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Variants that introduce premature termination codons in TSC1 are responsible for almost all TSC1 associated tuberous sclerosis cases (Curatolo 2015). Based on available information, this variant is considered to be pathogenic. References: Curatolo P et al. Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. Semin Pediatr Neurol. 2015 Dec;22(4):259-73. PMID: 26706013. Jiang T et al. Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy. Front Mol Neurosci. 2021 Aug 19;14:699574. PMID: 34489640. Peron A et al. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2. Eur J Med Genet. 2018 Jul;61(7):403-410. PMID: 29432982. Pompili G et al. Magnetic resonance imaging of renal involvement in genetically studied patients with tuberous sclerosis complex. Eur J Radiol. 2009 Nov;72(2):335-41. PMID: 18835118. -
Tuberous sclerosis 1 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with tuberous sclerosis complex (PMID: 29432982, 10533069, 28065512, 32313033). ClinVar contains an entry for this variant (Variation ID: 489349). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln794*) in the TSC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC1 are known to be pathogenic (PMID: 10227394, 17304050). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at